, Oncology letters. 14 (2017) 4751-4757.
[15] H. Wang and D. Li, Clinical significance of BANCR expression in hepatocellular carcinoma, World Chin J Digestol. 24 (2016) 6.
[16] N.N. Zhao, N.N. Zhao, C. Wang, et al., Downregulation of BRAF-activated non-protein coding RNA in patients with hepatitis B virus-associated hepatocellular carcinoma, Oncology Letters. 15 (2018) 7794-7798.
[17] T. Zhou and Y. Gao, Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma, World journal of surgical oncology. 14 (2015) 8.
[18] M. Sun, X.H. Liu, K.M. Wang, et al., Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition, Molecular Cancer. 13 (2014) 68-68.
[19] S. Xue, S.-Q. Jiang, Q.-w. Li, et al., Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma, BMC urology. 18 (2018) 79.
[20] A. Stang, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, European Journal of Epidemiology. 25 (2010) 603-605.
[21] J.F. Tierney, L.A. Stewart, D. Ghersi, et al., Practical methods for incorporating summary time-to-event data into meta-analysis, 8 (2007) 16.
[22] S. Sadeghpour and S. Ghorbian, Evaluation of the potential clinical prognostic value of lncRNA-BANCR gene in esophageal squamous cell carcinoma, Molecular biology reports. 46 (2019) 991-995.
[23] Z.Q. Peng, R.B. Lu, D.M. Xiao, et al., Increased expression of the lncRNA BANCR and its prognostic significance in human osteosarcoma, Genetics & Molecular Research Gmr. 15 (2016).
[24] T. Liao, N. Qu, R.L. Shi, et al., BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer, Oncotarget. 8 (2016) 238-247.
[25] Y. Wang, X. Lin, X. Fu, et al., Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway, Oncology reports. 40 (2018) 859-866.
[26] J. Zhang, Y. Du, X. Zhang, et al., Downregulation ofBANCRPromotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways, Journal of Cancer. 9 (2018) 1318-1328.
[27] Y. Wang, Q. Guo, Y. Zhao, et al., BRAF‑activated long non‑coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma, Oncology letters. 8 (2014) 1947-1952.
[28] T. Liu, Y. Zhao, L. Wang, et al., Effects of serine/threonine-protein kinase B-Raf-activated long-chain non-coding RNA on apoptosis and autophagy in thyroid carcinoma cells, Zhong nan da xue xue bao. Yi xue ban= Journal of Central South University. Medical sciences. 43 (2018) 747-753.
[29] R. Wang, L. Du, X. Yang, et al., Identification of long noncoding RNAs as potential novel diagnosis and prognosis biomarkers in colorectal cancer, Journal of cancer research and clinical oncology. 142 (2016) 2291-2301.
[30] X. Shen, Y. Bai, B. Luo, et al., Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer, Biological research. 50 (2017) 32.
[31] A. He, Y. Liu, Z. Chen, et al., Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer, Journal of Experimental & Clinical Cancer Research. 35 (2016) 125.
[32] L. Ruiya, Z. Lingli, J. Lizhou, et al., Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation, Plos One. 9 (2014) e100893.
[33] J. Jiang, S.H. Shi, X.J. Li, et al., Long non‑coding RNA BRAF‑regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer, Oncology letters. 15 (2018) 9543-9552.
[34] K. Lou, Z. Li, P. Wang, et al., Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion, Eur Rev Med Pharmacol Sci. 22 (2018) 1358-1365.
[35] Z. Liu, T. Yang, Z. Xu, et al., Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma, Biomedicine & Pharmacotherapy. 82 406-412.
[36] D. Wang, D. Wang, N. Wang, et al., Long non-coding RNA BANCR promotes endometrial cancer cell proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK signaling pathway, Cellular physiology and biochemistry. 40 (2016) 644-656.
[37] H. Wang, N. Zhang, G. Li, et al., Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease, Life sciences. 231 (2019) 116510.
[38] X. Zhang, X. Zou, Y. Li, et al., Downregulation of lncRNA BANCR participates in the development of retinopathy among diabetic patients, Experimental and therapeutic medicine. 17 (2019) 4132-4138.
[39] R.J. Flockhart, D.E. Webster, K. Qu, et al., BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration, Genome Research. 22 (2012) 1006.
[40] S. Su, J. Gao, T. Wang, et al., Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma, Tumor Biology. 36 (2015) 7205-7211.
[41] H. Wang and D. Li, Clinical significance of BANCR expression in hepatocellular carcinoma, World Chin J Digestol. 24 (2016) 196-202.
[42] J. Zhang, Y. Du, X. Zhang, et al., Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways, Journal of Cancer. 9 (2018) 1318-1328.
[43] Q. Guo, Y. Zhao, J. Chen, et al., BRAF‑activated long non‑coding RNA contributes to colorectal cancer migration by inducing epithelial‑mesenchymal transition, Oncology letters. 8 (2014) 869-875.
[44] S. Ma, D. Yang, Y. Liu, et al., LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer, Aging (Albany NY). 10 (2018) 2062.
[45] Y.H. Fan, M.H. Ye, L. Wu, et al., BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: A meta-analysis, Oncotarget. 8 (2017) 6295-6303.
[46] L. Hu, M. Li, L. Pu, et al., The different prognostic value of long non-coding RNA BANCR in human cancers, Minerva Medica. 108 (2017) 97-100.
TABLE 3 Subgroup analysis of the pooled HRs with BANCR expression in patients with cancer.
Note: OS: overall survival; DFS: disease-free survival; PFS: progression-free survival; Random: Random effects; Fixed: Fixed effects; directly: HR was extracted directly from the primary articles; indirectly: HR was extracted indirectly from the primary articles; NSCLC: non-small cell lung cancer; HCC: hepatocellular carcinoma; CRC: colorectal cancer; BC: breast cancer; ccRCC: clear cell renal cell carcinoma; GC: gastric cancer; LNM: lymphatic node metastasis; DM: distant metastasis; HTS: high tumor stage(III,IV);NA: not available; ESCC: esophagus cancer; directly: HR was extracted directly from article; OS: overall survival; DFS: disease free survival; RFS: recurrence free survival.
Thread
:
Are cruisers as pointless as I hear/read?
Archived Post
Lt. Commander
Join Date: Dec 2007
Posts: 120
# 38
02-24-2012, 11:21 AM
The tac captained Oddity, (that's 5 to go Frans), the USS Raoul Duke, I flew in Cure elite did well. Yes it blew up twice, but I was able to